Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg, Eric G. Neilson · Journal of Clinical Investigation · 2009
Somatic cells that change from one mature phenotype to another exhibit the property of plasticity. It is increasingly clear that epithelial and endothelial cells enjoy some of this plasticity, which is easily demonstrated by studying the process of epithelial-mesenchymal transition (EMT). Published reports from the literature typically rely on ad hoc criteria for determining EMT events; consequently, there is some uncertainty as to whether the same process occurs under different experimental conditions. As we discuss in this Personal Perspective, we believe that context and various changes in plasticity biomarkers can help identify at least three types of EMT and that using a collection of criteria for EMT increases the likelihood that everyone is studying the same phenomenon - namely, the transition of epithelial and endothelial cells to a motile phenotype.
Cited by 2,295 works. doi:10.1172/jci36183 Open-access PDF
Authors
References
- Tumors: Wounds That Do Not Heal
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- The basics of epithelial-mesenchymal transition
- Fibronectins: multifunctional modular glycoproteins.
- Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
- A molecular signature of metastasis in primary solid tumors
- Different intermediate-sized filaments distinguished by immunofluorescence microscopy.
- Complex networks orchestrate epithelial–mesenchymal transitions
- Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion.
- Fibroblasts in cancer